Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Horton

Showing results (481-490 of 538) with videos related to

Pageof 54
Sort By:
Journal of Proteomics|November 19, 2020
The effects of sample handling on proteomics assessed by reverse phase protein arrays (RPPA): Functional proteomic profiling in leukemiaTerzah M Horton, Fieke W Hoff, Anneke van Dijk, et al.
Blood|August 27, 2020
Tumor-associated myeloid cells provide critical support for T-ALLAram Lyu, Todd A Triplett, Seo Hee Nam, et al.
Mabs|April 4, 2013
Immune suppression in cynomolgus monkeys by XPro9523: an improved CTLA4-Ig fusion with enhanced binding to CD80, CD86 and neonatal Fc receptor FcRnMatthew J Bernett, Seung Y Chu, Irene Leung, et al.
AJR. American Journal of Roentgenology|April 24, 2019
Utility of CT Radiomics Features in Differentiation of Pancreatic Ductal Adenocarcinoma From Normal Pancreatic TissueLinda C Chu, Seyoun Park, Satomi Kawamoto, et al.
Pediatric Blood & Cancer|July 1, 2014
A Phase 2 study of bortezomib combined with either idarubicin/cytarabine or cytarabine/etoposide in children with relapsed, refractory or secondary acute myeloid leukemia: a report from the Children's Oncology GroupTerzah M Horton, John P Perentesis, Alan S Gamis, et al.
Journal of Hematology & Oncology|September 8, 2016
Proteasome subunit expression analysis and chemosensitivity in relapsed paediatric acute leukaemia patients receiving bortezomib-containing chemotherapyDenise Niewerth, Gertjan J L Kaspers, Gerrit Jansen, et al.
Blood|October 18, 2021
A gene expression-based model predicts outcome in children with intermediate-risk classical Hodgkin lymphomaRebecca L Johnston, Anja Mottok, Fong Chun Chan, et al.
British Journal of Haematology|April 18, 2022
Inhibition of the Sec61 translocon overcomes cytokine-induced glucocorticoid resistance in T-cell acute lymphoblastic leukaemiaLauren K Meyer, Cristina Delgado-Martin, Phillip P Sharp, et al.
Haematologica|September 24, 2013
Higher ratio immune versus constitutive proteasome level as novel indicator of sensitivity of pediatric acute leukemia cells to proteasome inhibitorsDenise Niewerth, Niels E Franke, Gerrit Jansen, et al.
Oncotarget|July 9, 2020
RSK inhibitor BI-D1870 inhibits acute myeloid leukemia cell proliferation by targeting mitotic exitHee-Don Chae, Ritika Dutta, Bruce Tiu, et al.
Pageof 54

Showing results (481-490 of 538) with videos related to

Sort By:
Pageof 54
Journal of Proteomics|November 19, 2020
The effects of sample handling on proteomics assessed by reverse phase protein arrays (RPPA): Functional proteomic profiling in leukemiaTerzah M Horton, Fieke W Hoff, Anneke van Dijk, et al.
Blood|August 27, 2020
Tumor-associated myeloid cells provide critical support for T-ALLAram Lyu, Todd A Triplett, Seo Hee Nam, et al.
Mabs|April 4, 2013
Immune suppression in cynomolgus monkeys by XPro9523: an improved CTLA4-Ig fusion with enhanced binding to CD80, CD86 and neonatal Fc receptor FcRnMatthew J Bernett, Seung Y Chu, Irene Leung, et al.
AJR. American Journal of Roentgenology|April 24, 2019
Utility of CT Radiomics Features in Differentiation of Pancreatic Ductal Adenocarcinoma From Normal Pancreatic TissueLinda C Chu, Seyoun Park, Satomi Kawamoto, et al.
Pediatric Blood & Cancer|July 1, 2014
A Phase 2 study of bortezomib combined with either idarubicin/cytarabine or cytarabine/etoposide in children with relapsed, refractory or secondary acute myeloid leukemia: a report from the Children's Oncology GroupTerzah M Horton, John P Perentesis, Alan S Gamis, et al.
Journal of Hematology & Oncology|September 8, 2016
Proteasome subunit expression analysis and chemosensitivity in relapsed paediatric acute leukaemia patients receiving bortezomib-containing chemotherapyDenise Niewerth, Gertjan J L Kaspers, Gerrit Jansen, et al.
Blood|October 18, 2021
A gene expression-based model predicts outcome in children with intermediate-risk classical Hodgkin lymphomaRebecca L Johnston, Anja Mottok, Fong Chun Chan, et al.
British Journal of Haematology|April 18, 2022
Inhibition of the Sec61 translocon overcomes cytokine-induced glucocorticoid resistance in T-cell acute lymphoblastic leukaemiaLauren K Meyer, Cristina Delgado-Martin, Phillip P Sharp, et al.
Haematologica|September 24, 2013
Higher ratio immune versus constitutive proteasome level as novel indicator of sensitivity of pediatric acute leukemia cells to proteasome inhibitorsDenise Niewerth, Niels E Franke, Gerrit Jansen, et al.
Oncotarget|July 9, 2020
RSK inhibitor BI-D1870 inhibits acute myeloid leukemia cell proliferation by targeting mitotic exitHee-Don Chae, Ritika Dutta, Bruce Tiu, et al.
Pageof 54